Join the webinar presenting the latest module of the Educational Program on Type 2 Diabetes Management and exploring modern strategies for managing T2DM by examining real-life patient cases.
Get to know about the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial, designed to assess the effects on major vascular outcomes of lowering the glycated hemoglobin value in patients with type 2 diabetes.